Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
Clinical trial NCT00289783 · COMPLETED
Trial details
- NCT number
- NCT00289783
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-22
- Primary completion
- 2007-08-27
- Enrollment
- 4441
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.